drugset / Trial / NCT00092651

A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)

NCT00092651

Phase 3 Completed 1398 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the lipid lowering effects of an investigational drug in patients with hypercholesterolemia (high cholesterol).

Timeline

Start
2002-09
Primary completion
2003-06
Completion
2003-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown
Subject Simvastatin Small molecule
Subject vytorin Unknown

Indications